News | News By Subject | News by Disease News By Date | Search News

Immune Disorder (non-specific) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bay Area’s GigaGen Develops Synthetic Immune System to Harness Antibodies     4/19/2016
With High-Powered Backing, Bay Area Vitesse Biologics is 'Getting Up to Speed'     10/23/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company     3/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
MD Anderson Cancer Center to Earn $100 Million From Intrexon (XON) and ZIOPHARM Oncology (ZIOP.OB) for Immunotherapy Game-changer     1/14/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)     7/31/2014
FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders     7/31/2014
Questcor Pharmaceuticals, Inc. (QCOR) Finally Fesses Up To Adverse Events Data For Acthar     7/14/2014
Agenus (AGEN) Could Net $100 Million From Cancer Immunotherapy Pact With Merck & Co., Inc. (MRK)     4/28/2014
Merck & Co., Inc. (MRK)'s Dust Mite Allergy Drug Reduces Symptoms In Phase 2b Study     3/5/2014
San Diego Startup Abide Therapeutics Strikes Immune Disorder Pact With Celgene (CELG), Financial Details Undisclosed     2/28/2014
CSL Behring Gains Approval to License Hizentra® in Japan for the Treatment of Primary Immunodeficiency and Secondary Immunodeficiency     9/27/2013
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives     5/15/2013

News from Around the Web
The Good And Bad Of Immunotherapy     9/7/2016
What Really Happens When Women Stop Taking Birth Control, National Institute of Environmental Health Sciences Study     8/5/2016
Will CAR-T Deliver On The Promise Of Widespread Therapeutic Improvement?     6/10/2016
Test Holds Potential To Diagnose Myriad Conditions With Drop Of Blood, University of Pittsburgh Study Reveals     6/10/2016
Global Antibiotics Threat: What’s Big Pharma Doing?     5/1/2014
Drug Resistant Superbugs A Serious Threat Worldwide, Says World Health Organization     4/30/2014
Can You Sleep Away Your Infection? University of Pennsylvania Study     4/24/2014
Researchers Combine Smallpox, Anthrax Vaccines, FDA and JDM Technologies Reveal     10/4/2010
Rare Brain Disease Yields to Immune Suppression, Hospital For Sick Children Study     10/4/2010
Can a Supplement Boost Immunity, Slow Aging? - University of Arizona Study     9/10/2010
Studies from Utrecht University, Utrecht Institute for Pharmaceutical Science in the Area of Immunization Published     8/23/2010
Old Drug Holds Promise Against Opportunistic Lung Bug, University of Rochester Medical Center Study     8/20/2010
Recovery Act Enables Research That Could Help Improve Vaccines And Therapeutics Funded by the National Institute of Allergy And Infectious Diseases (NIAID)     8/13/2010
Gene Therapy Benefits Persist in SCID, Necker-Enfants Malades Hospital Study     7/22/2010
New Genetic Cause Of A Fatal Immune Disorder, Geneviève de Saint Basile Research     11/3/2009

Press Releases
Shire (SHPG) Launches CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] In The U.S. For Primary Immunodeficiency     11/16/2016
Immune Therapeutics Announces Filing Acceptance Of New Drug Applications For Lodonal For The Treatment Of Patients With Human Immuno-Deficiency, Cancer And As An Immune Booster     10/26/2016
Eisai Inc. (ESALF.PK) Release: Preliminary Results From Lenvatinib + Pembrolizumab Phase 1b Clinical Study In Select Solid Tumors Presented At ESMO 2016     10/14/2016
Kezar Life Sciences Announces Initiation Of Phase 1 Clinical Program For Lead Candidate KZR-616, A First-In-Class Immunoproteasome Inhibitor     9/13/2016
Valensa International, LLC Announces Immunity-Enhancing Immunum Chewable Tablets     9/8/2016
ProMetic Life Sci (PFSCF.PK) Completes Adult Patients' Enrolment In Pivotal IVIG Phase 3 Clinical Trial     8/9/2016
Shire (SHPG) Launches Pediatric Indication For Immunodeficiency Treatment Hyqvia In Europe     7/21/2016
Array BioPharma (ARRY) Submits Binimetinib New Drug Application To U.S. FDA     7/1/2016
Curis (CRIS) Announces FDA Acceptance Of Investigational New Drug Application For CA-170, The First Orally Available Small Molecule To Target And Inhibit Immune Checkpoints     6/1/2016
Gene Therapy Pioneered At St. Jude Children's Research Hospital Shows Early Success Against "Bubble Boy" Disease     4/21/2016
Compugen Ltd. (CGEN) Achieves Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer (BAY)     4/18/2016
Soligenix (SNGX) Announces Issuance Of New Patents For Dusquetide     4/14/2016
SurePure Instrumental In Clinical Trial     4/7/2016
Atreca Announces Presentation Of Preclinical Data For Antibody Discovery Program     3/31/2016
Immune Pharma Announces Publication Of Preclinical Data In Support Of Its Bispecific Antibody Platform In The Journal Of Immunology     3/22/2016

//-->